From archneur.ama-assn.org
()
Multiple sclerosis
A community portal about Multiple sclerosis with blogs, videos, and photos. According to Wikipedia.org: Multiple sclerosis is a chronic, inflammatory disease that affects the central nervous system . MS can cause a variety of symptoms... [more]
A community portal about Multiple sclerosis with blogs, videos, and photos. According to Wikipedia.org: Multiple sclerosis is a chronic, inflammatory disease that affects the central nervous system . MS can cause a variety of symptoms, including changes in sensation, visual problems, muscle weakness, depression, difficulties with coordination and speech, severe fatigue, and pain. Although many patients lead full and rewarding lives, MS can cause impaired mobility and disability in more severe cases.
MS Awareness Bracelet
http://www.flickr.com/photos/jamilary/
Objective To characterize factors that contribute to symptomatic narcolepsy and excessive daytime sleepiness in neuromyelitis optica and multiple sclerosis.
Setting Japanese university hospitals.
Design Case study.
Patients Seven Japanese patients whose initial diagnoses were multiple sclerosis and who were exhibiting excessive daytime sleepiness.
Main Outcome Measures Lesions on magnetic resonance imaging, cerebrospinal fluid hypocretin...
- Magnetic resonance imaging characteristics of children and adults with... (brain.oxfordjournals.org)
- Panel Of Multiple Sclerosis Experts Provides Best Practice Treatment... (medicalnewstoday.com)
Background:
Statins have anti-inflammatory and immunomodulatory properties in addition to their lipid-lowering effects. Currently, the effects of statins on multiple sclerosis are still controversial. Therefore, randomized clinical trials are needed to provide better evidence on the therapeutic potential of statins in multiple sclerosis. The SWiss Atorvastatin and Interferon Beta-1b trial in Multiple Sclerosis (SWABIMS) evaluates the efficacy...
From biomedcentral.com
()
- Neurobiological mechanisms underlying emotional processing in relapsing... (brain.oxfordjournals.org)
- Phenotypical and functional characterization of T helper 17 cells in multiple... (brain.oxfordjournals.org)
- Recent developments in multiple sclerosis therapeutics (biomedcentral.com)
Biogen Idec (NASDAQ: BIIB) today announced that its oral compound BG-12 (dimethyl fumarate) achieved key milestones in clinical trials for multiple sclerosis (MS) and rheumatoid arthritis (RA). In recent months, the last patient was enrolled in the CONFIRM trial, the second of two Phase III trials designed to evaluate the efficacy and safety of BG-12 as a monotherapy in patients with relapsing-remitting multiple sclerosis (RRMS)...
More perspectives...
From medicalnewstoday.com
()
We established microRNA profiles from active and inactive multiple sclerosis lesions. Using laser capture microdissection from multiple sclerosis lesions to pool single cells and in vitro cultures, we assigned differentially expressed microRNA to specific cell types. Astrocytes contained all 10 microRNA that were most strongly upregulated in active multiple sclerosis lesions, including microRNA-155, which is known to modulate immune responses...
From brain.oxfordjournals.org
()
- Micro-ribonucleic acid profiling of multiple sclerosis lesions identifies... (brain.oxfordjournals.org)
Victoria multiple sclerosis patient wary of 'Liberation Procedure'Victoria Times Colonist... with an incurable disease like multiple sclerosis has taught self-described extreme-sports addict Joseph Hall to keep things moving on an even keel. ...and more »
More perspectives...
From news.google.com
()
Written by
Vreni
on
From:
blog.wellnesstips.ca
Written by
imelgrat
on
From:
smarticle.co.uk
Written by
brleee
on
From:
blog.itechtalk.com
